Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Ligia Carolina Facin: Investigating a Novel Therapeutic Strategy for ATTR-CM
Oct 5, 2026, 10:50

Ligia Carolina Facin: Investigating a Novel Therapeutic Strategy for ATTR-CM

Ligia Carolina Facin, Fellowship in Cardiac Amyloidosis at Ensino InCor, Cardio-Oncology Resident at Heart Institute, University of São Paulo (FMUSP), shared a post on LinkedIn:

“It was a great privilege to participate in the CLEOPATTRA Investigators’ Meeting, an international clinical trial investigating a novel therapeutic strategy for transthyretin amyloid cardiomyopathy (ATTR-CM).

Over the past few years, we have witnessed remarkable advances in the treatment of ATTR-CM.

Now, a new frontier is being explored: therapies aimed at removing amyloid deposits already present in cardiac tissue, with the potential to further transform the course of the disease.

Being part of a study investigating this innovative therapeutic approach is a unique opportunity to contribute to the evidence that may shape the future of cardiac amyloidosis treatment.

Science, international collaboration, and clinical research opening new perspectives for our patients.”

Ligia Carolina Facin

Stay updated with Hemostasis Today.